Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin versus atorvastatin follow-on study in type 2 diabetes mellitus with combined dyslipidemia
2005-006041-16Phase 3Completed
- Sponsor
- Kowa Research Europe
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of pitavastatin and atorvastatin in combined dyslipidaemia and type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Kowa Research Europe. Primary endpoint: Long-term safety and tolerability. Started Apr 2006; status: completed.
02
Drugs
pitavastatinatorvastatin
03
Conditions
combined dyslipidaemiatype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-006041-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006041-16.